Jay D. Raman, MD

Jay D. Raman, MD

Jay D. Raman, MD, FACS, is Professor and Interim Chair of the Department of Urology at Penn State Health Milton S. Hershey Medical Center. He received his undergraduate degree from the Massachusetts Institute of Technology (MIT) and graduated Alpha Omega Alpha (AOA) from Cornell University Medical College. Dr. Raman completed his urology residency at New York Presbyterian Hospital - Cornell Medical Center followed by a fellowship in laparoscopic and robotic surgery at the University of Texas Southwestern Medical Center in Dallas.

Dr. Raman's clinical practice focuses on robotic-assisted surgery for upper and lower tract urologic cancers, having completed over 2,500 cases. His clinical research centers on quality of care for prostate cancer patients, novel treatments for upper-tract urothelial carcinoma, biomarkers for urinary tract cancers, prostate biopsy infections, as well as complications of urologic surgery. To date, he has co-authored over 350 manuscripts, book chapters, and editorials and serves on the editorial board for three journals and as a reviewer for 12 journals.

Dr. Raman is currently Chair of the American Urologic Association (AUA) Office of Education and Past-President of the Mid-Atlantic AUA section. He also serves on the Urology Advisory Council for the American College of Surgeons.

Talks by Jay D. Raman, MD

Kidney Preservation for Upper-Tract Urothelial Carcinoma: Current State and Future Directions

Kidney Preservation for Upper-Tract Urothelial Carcinoma: Current State and Future Directions

Posted by | Aug 2024

Jay D. Raman, MD, examines the evolving strategies and treatment paradigms aimed at preserving kidney function in patients with upper-tract urothelial carcinoma (UTUC). Dr. Raman highlights the clinical significance of kidney preservation, given the substantial morbidity associated with radical nephroureterectomy, the traditional standard of care.

Dr. Raman emphasizes the importance of patient selection, detailing how advancements in diagnostic imaging and risk stratification enable more precise identification of candidates for kidney-sparing approaches. He discusses the role of endoscopic management, such as laser ablation and segmental ureterectomy, underscoring their efficacy and safety in appropriately selected patients. Furthermore, he examines the integration of perioperative therapies, including intraluminal chemotherapy and immunotherapy, as adjuncts to enhance local control and reduce recurrence rates.

Read More
Imaging for High-Risk Prostate Cancer: The Guidelines and Beyond

Imaging for High-Risk Prostate Cancer: The Guidelines and Beyond

Posted by | Aug 2024

Jay D. Raman, MD, addresses imaging in managing high-risk prostate cancer while providing a comprehensive overview of current guidelines and advancements beyond established protocols.

He details the standard imaging modalities recommended for high-risk prostate cancer, including multiparametric MRI, CT scans, and bone scans. He emphasizes the importance of accurate staging and risk stratification, highlighting how these imaging techniques contribute to treatment planning and prognosis.

Dr. Raman explores emerging imaging technologies that improve the detection and management of high-risk prostate cancer. He reviews the latest advancements in PET imaging, including the use of PSMA-PET, which offers superior sensitivity and specificity in detecting metastatic disease.

Read More
Infections Following Prostate Needle Biopsy – An Evidence-Based Approach to Tackling A Common Problem

Infections Following Prostate Needle Biopsy – An Evidence-Based Approach to Tackling A Common Problem

Posted by | Aug 2024

Jay D. Raman, MD addresses infections following prostate needle biopsy, presenting an evidence-based approach to managing this common problem. He notes the prevalence of infections following prostate needle biopsy in recent years, attributing this increase to antibiotic resistance and the inherent risks associated with transrectal biopsy procedures.

At the core of his presentation, Dr. Raman reviews current evidence and guidelines for preventing infections post-biopsy. He examines the role of prophylactic antibiotics and emphasizes the importance of tailoring antibiotic prophylaxis to individual patient risk profiles, including prior infection history, local resistance patterns, and patient comorbidities.

Dr. Raman also explores alternative biopsy techniques aimed at reducing infection rates. A shift towards transperineal biopsy approaches has demonstrated lower infection risks compared to traditional transrectal methods. The presentation includes an analysis of the benefits and limitations of these techniques, supported by recent clinical data.

Read More

Join the GRU Community

- Why Join? -